Christina Rossi Blueprint Medicines Corp (BPMC) insider trading activity

BPMC Quotes by TradingView

Christina Rossi is Chief Operating Officer of Blueprint Medicines Corp. Currently has a direct ownership of 0 shares of BPMC, which is worth approximately $0. The most recent transaction as insider was on Jul 17, 2025, when has been sold 82,374 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Christina Rossi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 17 2025
SELL
Sale (or disposition) back to the issuer
-
82,374 Reduced 79.97%
20,628 Common Stock
Jul 17 2025
SELL
Disposition due to a tender of shares in a change of control transaction
-
20,628 Reduced 100.0%
0 Common Stock
Jul 17 2025
BUY
Grant, award, or other acquisition
-
39,456 Added 27.7%
103,002 Common Stock
Jul 03 2025
SELL
Open market or private sale
$150,309 $128.25 p/Share
1,172 Reduced 1.81%
63,546 Common Stock
May 19 2025
SELL
Open market or private sale
$229,310 $100.84 p/Share
2,274 Reduced 3.39%
64,718 Common Stock
May 05 2025
SELL
Open market or private sale
$232,584 $102.28 p/Share
2,274 Reduced 3.28%
66,992 Common Stock
Mar 24 2025
SELL
Open market or private sale
$216,075 $95.02 p/Share
2,274 Reduced 3.18%
69,266 Common Stock
Mar 05 2025
SELL
Open market or private sale
$576,756 $88.8 p/Share
6,495 Reduced 8.32%
71,540 Common Stock
Mar 01 2025
BUY
Grant, award, or other acquisition
-
13,200 Added 14.47%
78,035 Common Stock
Feb 20 2025
SELL
Open market or private sale
$216,348 $95.14 p/Share
2,274 Reduced 3.39%
64,835 Common Stock
Jan 21 2025
SELL
Open market or private sale
$251,026 $110.39 p/Share
2,274 Reduced 3.28%
67,109 Common Stock
Dec 18 2024
SELL
Open market or private sale
$218,736 $96.19 p/Share
2,274 Reduced 3.17%
69,383 Common Stock
Nov 27 2024
SELL
Open market or private sale
$216,257 $95.1 p/Share
2,274 Reduced 3.08%
71,657 Common Stock
Jul 01 2024
BUY
Grant, award, or other acquisition
-
9,625 Added 11.52%
73,931 Common Stock
Mar 07 2024
SELL
Open market or private sale
$550,488 $90.69 p/Share
6,070 Reduced 8.63%
64,306 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
15,000 Added 17.57%
70,376 Common Stock
Mar 06 2023
SELL
Open market or private sale
$137,655 $45.0 p/Share
3,059 Reduced 5.23%
55,376 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
15,000 Added 20.43%
58,435 Common Stock
Nov 03 2022
SELL
Open market or private sale
$24,112 $45.24 p/Share
533 Reduced 1.21%
43,435 Common Stock
Mar 07 2022
SELL
Open market or private sale
$58,831 $56.19 p/Share
1,047 Reduced 2.3%
44,479 Common Stock
Mar 03 2022
SELL
Open market or private sale
$72,155 $60.28 p/Share
1,197 Reduced 2.56%
45,526 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
15,000 Added 24.3%
46,723 Common Stock
Nov 03 2021
SELL
Open market or private sale
$56,644 $110.85 p/Share
511 Reduced 1.15%
43,968 Common Stock
Mar 04 2021
SELL
Open market or private sale
$119,402 $87.86 p/Share
1,359 Reduced 4.11%
31,723 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
13,062 Added 28.31%
33,082 Common Stock

Also insider at

XLO
Xilio Therapeutics, Inc. Healthcare
CR

Christina Rossi

Chief Operating Officer
Cambridge, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BPMC